Bg Medicine Inc (BGMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,303 | -4,401 | -3,378 | -1,348 | -8,064 |
| Depreciation Amortization | 87 | 69 | 52 | 29 | 131 |
| Accounts receivable | -158 | -130 | -231 | 42 | 145 |
| Other Working Capital | -24 | 371 | -70 | -329 | -1,127 |
| Other Operating Activity | 1,731 | 1,541 | 1,409 | 215 | 748 |
| Operating Cash Flow | $-3,667 | $-2,550 | $-2,218 | $-1,391 | $-8,167 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 13 | 13 | 13 | N/A | N/A |
| Investing Cash Flow | $13 | $13 | $13 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 500 | 500 | 500 | N/A | N/A |
| Debt Repayment | -2,984 | -2,984 | -2,240 | -1,120 | -4,480 |
| Common Stock Issued | 2,500 | 2,500 | N/A | 0 | 9,262 |
| Other Financing Activity | 1,040 | 1,040 | 0 | 0 | -243 |
| Financing Cash Flow | $1,056 | $1,056 | $-1,740 | $-1,120 | $4,539 |
| Beginning Cash Position | 4,123 | 4,123 | 4,123 | 4,123 | 7,751 |
| End Cash Position | 1,525 | 2,642 | 178 | 1,612 | 4,123 |
| Net Cash Flow | $-2,598 | $-1,481 | $-3,945 | $-2,511 | $-3,628 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,667 | -2,550 | -2,218 | -1,391 | -8,167 |
| Free Cash Flow | -3,667 | -2,550 | -2,218 | -1,391 | -8,167 |